Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial
- 7 April 2005
- journal article
- clinical trial
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (5) , 287-294
- https://doi.org/10.1016/s1470-2045(05)70100-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter StudyJournal of Clinical Oncology, 2004
- Update on Locally Advanced Breast CancerThe Oncologist, 2003
- Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials—Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?Journal of Clinical Oncology, 2003
- Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter StudyJournal of Clinical Oncology, 2003
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Summary measures and statistics in the analysis of quality of life data: an example from an EORTC–NCIC–SAKK locally advanced breast cancer studyEuropean Journal Of Cancer, 2000
- Interpreting the significance of changes in health-related quality-of-life scores.Journal of Clinical Oncology, 1998
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990